Arecor Therapeutics plc (LON:AREC – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as GBX 48 ($0.62) and last traded at GBX 48 ($0.62), with a volume of 11 shares traded. The stock had previously closed at GBX 49.50 ($0.64).
Arecor Therapeutics Trading Up 0.7 %
The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51. The firm’s 50 day simple moving average is GBX 53.77 and its 200-day simple moving average is GBX 66.37. The company has a market capitalization of £18.63 million, a PE ratio of -1.74 and a beta of -0.18.
Arecor Therapeutics Company Profile
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
See Also
- Five stocks we like better than Arecor Therapeutics
- Most active stocks: Dollar volume vs share volume
- FedEx Delivers Another Crushing Blow to Its Stock Price
- How to Plot Fibonacci Price Inflection Levels
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
